{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:13:07Z","timestamp":1775682787619,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T00:00:00Z","timestamp":1485561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C0061"],"award-info":[{"award-number":["HI16C0061"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00296-016-3649-2","type":"journal-article","created":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T02:18:46Z","timestamp":1485569926000},"page":"975-982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis"],"prefix":"10.1007","volume":"37","author":[{"name":"For the BIOPSY and KORONA investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Kyoung","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Bum","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoung","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Young","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon-Suk","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Yoon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Tae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Jae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Bum","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoun Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaejoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jisoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Su","family":"Nah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Cheol","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,28]]},"reference":[{"key":"3649_CR1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:625\u2013639","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3649_CR2","first-page":"492509","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492\u2013509","journal-title":"Ann Rheum Dis"},{"key":"3649_CR3","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","volume":"69","author":"JR O\u2019Dell","year":"2010","unstructured":"McInnes IB1, O\u2019Dell JR (2010) State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 69:1898\u20131906","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3649_CR4","doi-asserted-by":"publisher","first-page":"e0119683","DOI":"10.1371\/journal.pone.0119683","volume":"17","author":"JT Joensuu","year":"2015","unstructured":"Joensuu JT, Huoponen S, Aaltonen KJ, Konttinen YT, Nordstr\u00f6m D, Blom M (2015) The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review. PLoS One 17(10):e0119683. doi:\n10.1371\/journal.pone.0119683","journal-title":"PLoS One"},{"key":"3649_CR5","first-page":"307318","volume":"369","author":"JR O\u2019Dell","year":"2013","unstructured":"O\u2019Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR et al (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 369:307\u2013318","journal-title":"N Engl J Med"},{"key":"3649_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.24588","volume":"61","author":"B Fautrel","year":"2009","unstructured":"Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM et al (2009) Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists\u2019 preferences. Arthritis Rheum 61:425\u2013434","journal-title":"Arthritis Rheum"},{"key":"3649_CR7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/ard.2003.019422","volume":"63","author":"L Fraenkel","year":"2004","unstructured":"Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR (2004) Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis 63:1372\u20131378","journal-title":"Ann Rheum Dis"},{"key":"3649_CR8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/acr.22265","volume":"66","author":"C Poulos","year":"2014","unstructured":"Poulos C, Hauber AB, Gonz\u00e1lez JM, Turpcu A (2014) Patients\u2019 willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) 66:1008\u20131015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3649_CR9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.semarthrit.2011.09.007","volume":"41","author":"YK Sung","year":"2012","unstructured":"Sung YK, Cho SK, Choi CB, Park SY, Shim J, Ahn JK et al (2012) Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin Arthritis Rheum 41:745\u2013751","journal-title":"Semin Arthritis Rheum"},{"key":"3649_CR10","doi-asserted-by":"crossref","first-page":"334342","DOI":"10.1002\/art.37723","volume":"65","author":"MC Wasko","year":"2013","unstructured":"Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM (2013) Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 65:334\u2013342","journal-title":"Arthritis Rheum"},{"key":"3649_CR11","doi-asserted-by":"crossref","first-page":"291298","DOI":"10.1097\/BOR.0b013e32832a2f1c","volume":"21","author":"NB Klarenbeek","year":"2009","unstructured":"Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA (2009) The BeSt story: on strategy trials in rheumatoid arthritis. Curr Opin Rheumatol 21:291\u2013298","journal-title":"Curr Opin Rheumatol"},{"key":"3649_CR12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/ard.2009.126748","volume":"69","author":"R Knevel","year":"2010","unstructured":"Knevel R, Schoels M, Huizinga TW, Aletaha D, Burmester GR, Combe B (2010) Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:987\u2013994","journal-title":"Ann Rheum Dis"},{"key":"3649_CR13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","volume":"353","author":"T M\u00f6tt\u00f6nen","year":"1999","unstructured":"M\u00f6tt\u00f6nen T, Hannonen P, Leirisalo-Repo M, Nissil\u00e4 M, Kautiainen H, Korpela M et al (1999) Comparison of combination therapywith single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. The Lancet 353:1568\u20131573","journal-title":"The Lancet"},{"key":"3649_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","volume":"146","author":"YP Goekoop-Ruiterman","year":"2007","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM et al (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146:406\u2013415","journal-title":"Ann Intern Med"},{"key":"3649_CR15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/art.23449","volume":"58","author":"SA Saunders","year":"2008","unstructured":"Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD et al (2008) Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 58:1310\u20131317","journal-title":"Arthritis Rheum"},{"key":"3649_CR16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/rheumatology\/41.8.892","volume":"41","author":"GF Ferraccioli","year":"2002","unstructured":"Ferraccioli GF, Gremese E, Tomietto P, Favret G, Damato R, Di Poi E (2002) Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years. Rheumatology (Oxford) 41:892\u2013898","journal-title":"Rheumatology (Oxford)"},{"key":"3649_CR17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/annrheumdis-2013-204128","volume":"74","author":"M Neovius","year":"2015","unstructured":"Neovius M, Arkema EV, Olsson H, Eriksson JK, Kristensen LE, Simard JF et al (2015) Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab. Ann Rheum Dis 74:354\u2013360","journal-title":"Ann Rheum Dis"},{"key":"3649_CR18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.21570","volume":"54","author":"LE Kristensen","year":"2006","unstructured":"Kristensen LE, Saxne T, Geborek P (2006) The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden. Arthritis Rheum 54:600\u2013606","journal-title":"Arthritis Rheum"},{"key":"3649_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"ML Hetland","year":"2010","unstructured":"Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al (2010) Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum 62:22\u201332","journal-title":"Arthritis Rheum"},{"key":"3649_CR20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/annrheumdis-2011-150573","volume":"71","author":"JD Greenberg","year":"2012","unstructured":"Greenberg JD, Reed G, Decktor D, Harrold L, Furst D, Gibofsky A et al (2012) A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically na\u00efve and switched rheumatoid arthritis patients: results from the US CORRONA registry. Ann Rheum Dis 71:1134\u20131142","journal-title":"Ann Rheum Dis"},{"key":"3649_CR21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.semarthrit.2013.07.011","volume":"43","author":"I Flouri","year":"2014","unstructured":"Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L et al (2014) Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: low rates of remission and 5-year drug survival. Semin Arthritis Rheum 43:447\u2013457","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3649-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T10:35:19Z","timestamp":1494930919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3649-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,28]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3649"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3649-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,28]]}}}